Literature DB >> 20388556

A case of Kearns-Sayre syndrome with two novel deletions (9.768 and 7.253 kb) of the mtDNA associated with the common deletion in blood leukocytes, buccal mucosa and hair follicles.

Emna Mkaouar-Rebai1, Imen Chamkha, Thouraya Kammoun, Imen Chabchoub, Hajer Aloulou, Nourhene Fendri, Mongia Hachicha, Faiza Fakhfakh.   

Abstract

Kearns-Sayre syndrome is a mitochondrial disorder characterized by the emergence before the age of 20 years of progressive external ophthalmoplegia, pigmentary retinopathy, with other heterogeneous clinical manifestations. Generally, mitochondrial DNA deletions were associated with KSS but the size and position of these deletions differ among patients. This study reported a Tunisian patient with typical features of KSS. Long-range PCR amplification of the mtDNA in different tissues from this patient showed multiple mitochondrial deletions: two novel 9.768 and 7.253 kb deletions spanning respectively nucleotides 6124-15,893 and 8572-15,826 associated with the common 4.977 kb deletion. (c) 2010 Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388556     DOI: 10.1016/j.mito.2010.04.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  3 in total

1.  Choroid plexus failure in the Kearns-Sayre syndrome.

Authors:  Reynold Spector; Conrad E Johanson
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-23

2.  DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase.

Authors:  Sanjay Kumar Bharti; Joshua A Sommers; Jun Zhou; Daniel L Kaplan; Johannes N Spelbrink; Jean-Louis Mergny; Robert M Brosh
Journal:  J Biol Chem       Date:  2014-09-05       Impact factor: 5.157

3.  Ophthalmoplegia in Mitochondrial Disease.

Authors:  Sang Jun Lee; Ji Hoon Na; Jinu Han; Young Mock Lee
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.